Long-Read Metagenomics Global Market Report 2026

Long-read metagenomics is a genomic analysis technique that examines genetic material collected directly from complex biological or environmental samples using sequencing technologies capable of producing extended DNA sequence reads. This method supports more complete genome reconstruction, improved identification of genetic relationships, and enhanced analysis of diverse microbial communities present within a sample.

The primary sequencing technology types of long-read metagenomics consist of PacBio SMRT, Oxford Nanopore, and other sequencing technologies. PacBio SMRT is a long-read sequencing platform that enables real-time analysis of DNA molecules for comprehensive microbial and genomic characterization. These technologies are developed for sample types including human, animal, environmental, plant, and other sample categories. They utilize technology modalities such as single-molecule real-time sequencing, nanopore sequencing, and synthetic long-read or linked-read assays and are adopted by end users including academic and research institutes, hospitals and clinics, biotechnology and pharmaceutical companies, and others.

Tariffs are influencing the long-read metagenomics market by raising the cost of importing advanced sequencing instruments, specialized reagents, flow cells, and bioinformatics hardware essential for high-precision genomic analysis. This is causing procurement delays and slowing the adoption of long-read sequencing technologies across research institutions, biotechnology companies, and clinical laboratories, particularly in import-reliant regions such as Asia-Pacific and Latin America. Equipment- and consumable-intensive segments, including nanopore sequencing platforms and SMRT sequencing systems, are experiencing the greatest impact because of their dependence on globally distributed supply chains and specialized semiconductor components. However, tariffs are also promoting the localization of sequencing equipment manufacturing, diversification of supplier networks, and greater investment in domestic genomics infrastructure, ultimately enhancing long-term market resilience and innovation capacity.

The long-read metagenomics market research report is one of a series of new reports from The Business Research Company that provides long-read metagenomics market statistics, including long-read metagenomics industry global market size, regional shares, competitors with a long-read metagenomics market share, detailed long-read metagenomics market segments, market trends and opportunities, and any further data you may need to thrive in the long-read metagenomics industry. This long-read metagenomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The long-read metagenomics market size has grown exponentially in recent years. It will grow from $1.79 billion in 2025 to $2.16 billion in 2026 at a compound annual growth rate (CAGR) of 21.1%. The growth in the historic period can be attributed to decline in dna sequencing costs, expansion of next generation sequencing platforms, growth in microbiome research studies, increased funding for genomic research programs, development of early metagenomic assembly tools.

The long-read metagenomics market size is expected to see exponential growth in the next few years. It will grow to $4.69 billion in 2030 at a compound annual growth rate (CAGR) of 21.3%. The growth in the forecast period can be attributed to adoption of precision medicine approaches, expansion of clinical metagenomics diagnostics, rise in real time pathogen monitoring systems, integration of ai driven genomic analytics, increased demand for portable sequencing solutions. Major trends in the forecast period include high-resolution microbial strain resolution using long-read sequencing, advanced error correction and polishing algorithms for metagenomic assemblies, real-time pathogen surveillance through environmental dna sequencing, ultra-deep metagenomic profiling for rare species detection, improved sample preparation techniques for high molecular weight dna extraction.

The increasing burden of infectious diseases is expected to accelerate the growth of the long-read metagenomics market in the coming years. Infectious diseases are illnesses caused by disease-causing microorganisms, including bacteria, viruses, fungi, and parasites, which can spread through direct or indirect transmission among humans, animals, or environmental sources. The growing prevalence of infectious diseases is attributed to the emergence of antimicrobial-resistant pathogens and the increasing occurrence of worldwide disease outbreaks. Long-read metagenomics contributes to infectious disease control by allowing accurate detection of pathogens, identification of antimicrobial resistance genes, and analysis of genomic variations from complex clinical and environmental samples in real time. Long-read metagenomics enhances disease surveillance, supports rapid pathogen identification, and improves epidemiological monitoring within healthcare and public health systems. For instance, in October 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental public health organization, around 8.2 million people were newly diagnosed with tuberculosis in 2023, compared with 7.5 million cases in 2022. Therefore, the increasing prevalence of infectious diseases is driving the growth of the long-read metagenomics market.

Key companies operating in the long-read metagenomics market are focusing on developing advanced solutions, such as AI-powered genomic analysis platforms, to improve variant detection accuracy, automate complex sequence interpretation, and reduce downstream bioinformatics costs. AI-powered genomic analysis platforms are advanced computational systems that combine machine learning algorithms with long-read sequencing data to identify structural genomic variations, reconstruct plasmids, and deliver high-resolution microbial characterization with greater speed and precision. For example, in February 2024, PacBio, a US-based biotechnology company specializing in long-read sequencing technologies, launched the HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for its Revio sequencing system. The new high-throughput library preparation solutions were designed to accelerate long-read sequencing workflows for microbial and metagenomic applications. The kits enable automated sample preparation, improved scalability, reduced workflow time, and lower sequencing costs while supporting high accuracy. HiFi long-read sequencing supports complex metagenome assembly and microbial community analysis.

In July 2024, Oxford Nanopore Technologies, a UK-based biotechnology company specializing in nanopore-based long-read sequencing technologies, partnered with Plasmidsaurus to broaden the application of nanopore-based long-read sequencing across microbial genomics, plasmid analysis, and metagenomic sequencing workflows. The collaboration was intended to enhance sequencing accuracy, improve scalability, strengthen microbial genome assembly, and enable faster characterization of complex microbial communities for advanced metagenomics research and clinical applications. Plasmidsaurus is a US-based sequencing company specializing in plasmid, microbial, and long-read sequencing services.

Major companies operating in the long-read metagenomics market report are Illumina Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., New England Biolabs Inc., MGI Tech Co. Ltd., Element Biosciences Inc., Zymo Research Corporation, CD Genomics, Plasmidsaurus Inc., BaseClear B.V., Nucleome Informatics Private Limited, Sage Science Inc., MicrobesNG Ltd., Phase Genomics Inc., Universal Sequencing Technology Corporation, Biolome Inc., Thermo Fisher Scientific Inc., 10x Genomics Inc., Revvity Inc., Azenta US Inc., Takara Bio Inc.

North America was the dominating region in the long-read metagenomics market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the long-read metagenomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the long-read metagenomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The long-read metagenomics consists of revenues earned by entities by providing services such as metagenomic sequencing, high-throughput hybrid sequencing, sample processing, de novo assembly, structural variant identification, native epigenetic modification mapping, real-time adaptive sequencing, and custom bioinformatics analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The long-read metagenomicss market also includes sales of sequencing instruments, sequencing chips, automated library preparation kits, and high-molecular-weight (HMW) DNA extraction kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Long-Read Metagenomics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses long-read metagenomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for long-read metagenomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The long-read metagenomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Sequencing Technology Type: PacBio SMRT; Oxford Nanopore; Other Sequencing Technology Types
• 2) By Sample Type: Human; Animal; Environmental; Plant; Other Sample Types
• 3) By Technology Modality Type: Single-Molecule Real-Time Sequencing; Nanopore Sequencing; Synthetic Long-Read Or Linked-Read Assays
• 4) By End User Type: Academic And Research Institutes; Hospitals And Clinics; Biotechnology And Pharmaceutical Companies; Other End User Types
• Subsegments:
• 1) By PacBio SMRT: High Fidelity Sequencing; Continuous Long Read Sequencing
• 2) By Oxford Nanopore: Ultra Long Read Nanopore Sequencing; Short To Medium Long Read Nanopore Sequencing
• 3) By Other Sequencing Technology Types: Synthetic Long Read Sequencing; Linked Read Sequencing
• Companies Mentioned: Illumina Inc.; QIAGEN N.V.; BGI Genomics Co. Ltd.; Novogene Co. Ltd.; Oxford Nanopore Technologies plc; Pacific Biosciences of California Inc.; New England Biolabs Inc.; MGI Tech Co. Ltd.; Element Biosciences Inc.; Zymo Research Corporation; CD Genomics; Plasmidsaurus Inc.; BaseClear B.V.; Nucleome Informatics Private Limited; Sage Science Inc.; MicrobesNG Ltd.; Phase Genomics Inc.; Universal Sequencing Technology Corporation; Biolome Inc.; Thermo Fisher Scientific Inc.; 10x Genomics Inc.; Revvity Inc.; Azenta US Inc.; Takara Bio Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.